-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
TherapeuticsMD, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2011 to Q1 2025.
- TherapeuticsMD, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was -$32K.
- TherapeuticsMD, Inc. annual Income Tax Expense (Benefit) for 2024 was -$31K, a 27.9% increase from 2023.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)